Literature DB >> 8152807

Analysis of p53 in human cutaneous melanoma cell lines.

X Montano1, M Shamsher, P Whitehead, K Dawson, J Newton.   

Abstract

Mutations in the p53 tumour suppressor gene have been detected in a variety of human malignancies. Mutations have been found predominantly in conserved regions two to five. Our aim was to analyse p53 at the protein and DNA level in seven melanoma cell lines of cutaneous origin (HMB-2, DX3, LT5.1, MJM, SK23, A375P and A375M), including two parental/metastatic derivatives (A375P and A375M; DX3 and LT5.1). By immunohistochemical staining with three mouse monoclonal antibodies and a rabbit polyclonal serum, it was possible to observe differential nuclear expression of p53. The quantitation of p53 protein levels by ELISA correlated with the nuclear staining pattern. Western blotting showed an intact p53 protein in all cell lines; p53 was polymorphic in three cell lines (MJM, A375P and A375M). DNA sequencing studies showed that all cell lines had wild type p53. These results suggest that p53 is unlikely to play a significant role in the genesis of cutaneous melanoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152807

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

Review 1.  Bugs as drugs for cancer.

Authors:  Eleanor J Cheadle; Andrew M Jackson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

2.  The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.

Authors:  Jing Lin; Qingyuan Yang; Paul T Wilder; France Carrier; David J Weber
Journal:  J Biol Chem       Date:  2010-06-29       Impact factor: 5.157

3.  p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.

Authors:  Tamara Terzian; Enrique C Torchia; Daisy Dai; Steven E Robinson; Kazutoshi Murao; Regan A Stiegmann; Victoria Gonzalez; Glen M Boyle; Marianne B Powell; Pamela M Pollock; Guillermina Lozano; William A Robinson; Dennis R Roop; Neil F Box
Journal:  Pigment Cell Melanoma Res       Date:  2010-12       Impact factor: 4.693

4.  [Isolation of mitochondrial DNA binding proteins which are specific for maize cox1 promoter].

Authors:  V I Tarasenko; I Iu Subota; V F Kobzev; Iu M Konstantinov
Journal:  Mol Biol (Mosk)       Date:  2005 May-Jun

5.  Establishment of a dog model for the p53 family pathway and identification of a novel isoform of p21 cyclin-dependent kinase inhibitor.

Authors:  Jin Zhang; Xiangling Chen; Michael S Kent; Carlos O Rodriguez; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

6.  Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions.

Authors:  T Papp; M Jafari; D Schiffmann
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

7.  HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase.

Authors:  Ataman Sendoel; Ines Kohler; Christof Fellmann; Scott W Lowe; Michael O Hengartner
Journal:  Nature       Date:  2010-06-03       Impact factor: 49.962

8.  Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability.

Authors:  N M Hasan; G E Adams; M C Joiner; J F Marshall; I R Hart
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

9.  Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.

Authors:  S Rauth; A Green; J Kichina; A Shilkaitis
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  Reduced Apaf-1 expression in human cutaneous melanomas.

Authors:  D L Dai; M Martinka; J A Bush; G Li
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.